P. Kent Hawryluk
President, Chief Executive Officer and Director
Board Member
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | MBX Biosciences, Inc. (MBX) | President and Chief Executive Officer | $625,000 | $2,990,867 |
| 2024 | MBX Biosciences, Inc. (MBX) | President and Chief Executive Officer | $483,300 | $2,235,317 |
| 2023 | MBX Biosciences, Inc. (MBX) | President and Chief Executive Officer | $420,000 | $4,862,064 |
Executive changes
Earnings-call appearances
-
MBX Virtual Investor Event: Once-Weekly Canvuparatide Presentations at ENDO 20262026-06-12
MBX Biosciences, Inc. (MBX)
-
Jefferies Global Healthcare Conference2026-06-03
MBX Biosciences, Inc. (MBX)
-
Barclays 28th Annual Global Healthcare Conference2026-03-11
MBX Biosciences, Inc. (MBX)
-
MBX Biosciences, Inc. Q2 FY2025 Earnings Call2025-09-22
MBX Biosciences, Inc. (MBX)